09:35 EDT Sensei Biotherapeutics (SNSE) Inc trading halted, volatility trading pause
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNSE:
- Sensei Biotherapeutics Reports Promising Q2 2025 Results
- Sensei Biotherapeutics target adjusted to $30 from $5 at H.C. Wainwright
- Sensei Biotherapeutics reports Q2 EPS ($3.91) vs ($5.69) last year
- Sensei Biotherapeutics Regains Nasdaq Compliance
- Sensei price target raised to $35 at Stephens to reflect 1-for-20 reverse split